Bartholin gland cancer

Violante Di Donato, Assunta Casorelli, Erlisa Bardhi, Flaminia Vena, Claudia Marchetti, Ludovico Muzii, Pierluigi Benedetti Panici

Research output: Contribution to journalArticle


Introduction Bartholin gland carcinoma is an extremely rare condition. Because of its, phase III trials have not been carried out, there exists no unanimous consensus on treatment and guidelines are missing. Methods All studies reporting cases of Bartholin cancer were collected and screened for the evaluations. Baseline characteristics of studies were extracted and were queried in a database. Results A total number of 133 manuscripts collected were available for the review process, representing a total number of 275 reported cases. The histological type of Bartholin gland cancer was specified in 90.4% cases: 30.7% cases were squamous cell carcinoma, 29.6% adenoid cystic carcinoma, 25% adenocarcinomas. At multivariate analysis adenocarcinoma histotype and positive lymph node were statistical correlated with worse prognosis. Conclusion Bartholin gland cancer remains a challenge for gynecologic oncologists. To better understand and treat this disease, centralization to referral centers and design of multi institutional trials is crucial.
Original languageEnglish
Pages (from-to)1-11
Number of pages11
Publication statusPublished - 2017


  • Bartholin gland cancer
  • Bartholin gland carcinoma
  • Greater vestibular glands cancer
  • Major vestibular glands cancer


Dive into the research topics of 'Bartholin gland cancer'. Together they form a unique fingerprint.

Cite this